Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: June 2011

Chapter 12 - Cerebral vasospasm

References

1. FisherCM, OjemannRG. Basal rupture of saccular aneurysm. A pathological case report. J Neurosurg 1978;48:642–4.
2. HillsE, DunstanCR, WongSY, EvansRA. Bone histology in young adult osteoporosis. J Clin Pathol 1989;42:391–7.
3. AdamsHP, Jr. Prevention of brain ischemia after aneurysmal subarachnoid hemorrhage. Neurol Clin 1992;10:251–68.
4. KassellNF, TornerJC, HaleyEC, Jr., JaneJA, AdamsHP, KongableGL. The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 1990;73:18–36.
5. KindtGWMJ, PritzM, GiammotaS. Hypertension and hypervolemia as therapy for patients with vasospasm. Proceedings of the Second International Workshop, 1979:659.
6. SA M. Fluid management in sah. Neurologist. 1995;1:71–85.
7. AwadIA, CarterLP, SpetzlerRF, MedinaM, WilliamsFC, Jr.Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365–72.
8. KassellNF, PeerlessSJ, DurwardQJ, BeckDW, DrakeCG, AdamsHP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337–43.
9. NakajimaK, OkudaOHN, MaedaM. Hypervolemic hemodilution therapy for symptomatic cerebral vasospasm. In: Sanok tk, KassellNF, SasakiT, eds. Cerebral Vasospasm. Tokyo: University of Tokyo Press; 1990:352–3.
10. MedlockMD, DulebohnSC, ElwoodPW. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992;30:12–16.
11. TsengMY, HutchinsonPJ, RichardsHK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase ii randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 2009;111:171–80.
12. McGirtMJ, Garces AmbrossiGL, HuangJ, TamargoRJ. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. J Neurosurg 2009;110:968–74.
13. de OliveiraJG, BeckJ, UlrichC, RathertJ, RaabeA, SeifertV. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 2007;30:22–30; discussion 30–21.
14. Zwienenberg-LeeM, HartmanJ, RudisillN, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher Grade iii subarachnoid hemorrhage: results of a phase ii multicenter, randomized, clinical trial. Stroke 2008;39:1759–65.
15. MacdonaldRL, KassellNF, MayerS, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (conscious-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015–21.
16. MacdonaldRL, WeirBK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971–82.
17. FisherCM, KistlerJP, DavisJM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1–9.
18. WhiteRP, HagenAA, MorganH, DawsonWN, RobertsonJT. Experimental study on the genesis of cerebral vasospasm. Stroke 1975;6:52–7.
19. OsakaK. Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 1977;47:403–11.
20. MiyaokaM, NonakaT, WatanabeH, ChigasakiH, IshiS. [etiology and treatment of prolonged vasospasm –experimental and clinical studies – (author's transl)]. Neurol Med Chir (Tokyo) 1976;16:103–14.
21. SonobeM, SuzukiJ. Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir (Wien) 1978;44:97–106.
22. OkwuasabaF, CookD, WeirB. Changes in vasoactive properties of blood products with time and attempted identification of the spasmogens. Stroke 1981;12:775–80.
23. TodaN. Mechanisms of contracting action of oxyhemoglobin in isolated monkey and dog cerebral arteries. Am J Physiol 1990;258:H57–63.
24. FujiiS, FujitsuK. Experimental vasospasm in cultured arterial smooth-muscle cells. Part 1: Contractile and ultrastructural changes caused by oxyhemoglobin. J Neurosurg 1988;69:92–7.
25. ZazaA, KlineRP, RosenMR. Effects of alpha-adrenergic stimulation on intracellular sodium activity and automaticity in canine purkinje fibers. Circ Res 1990;66:416–26.
26. Ohtat kh, FamatsuN, YoshikawaY, SomedaK. Cerebral vasospasm and its relaxation response to vasodilation. Proceedings of the Second International Workshop. 1979
27. PetersonJW, KwunBD, HackettJD, ZervasNT. The role of inflammation in experimental cerebral vasospasm. J Neurosurg 1990;72:767–74.
28. AsanoTWT, TkakuraK, SanoK, ShimizuT. Activation of lipooxygenase pathway following sub-arachnoid hemorrage; its relevance to cerebral vasospasm. New York: Raven Press; 1988.
29. DupontJR, Van WartCA, KraintzL. The clearance of major components of whole blood from cerebrospinal fluid following simulated subarachnoid hemorrhage. J Neuropathol Exp Neurol 1961;20:450–5.
30. WahlgrenNG, BergstromK. Determination of haem derivatives in the cerebrospinal fluid – a semi-quantitative method. J Neurol Neurosurg Psychiatry 1983;46:653–8.
31. SasakiT, TanishimaT, AsanoT, MayanagiY, SanoK. Significance of lipid peroxidation in the genesis of chronic vasospasm following rupture of an intracranial aneurysm. Acta Neurochir Suppl (Wien) 1979;28:536–40.
32. WalkerV, PickardJD, SmytheP, EastwoodS, PerryS. Effects of subarachnoid haemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 1983;46:119–25.
33. Rodriguez y BaenaR, GaetaniP, GrignaniG, et al. Role of arachidonate metabolites in the genesis of cerebral vasospasm. Adv Prostaglandin Thromboxane Leukot Res 1987;17B:938–42.
34. PaolettiP, GaetaniP, GrignaniG, PacchiariniL, SilvaniV, Rodriguez y BaenaR. Csf leukotriene c4 following subarachnoid hemorrhage. J Neurosurg 1988;69:488–93.
35. WhiteRP. Vasospasm 1 Experimental Findings. In FoxJL, ed. Intra-cramial Aneurysms, Vol I New York: Springer-Verlag; 1983, pp. 218–49.
36. BoullinDJ, BuntingS, BlasoWP, HuntTM, MoncadaS. Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: Their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol 1979;7:139–47.
37. PaulKS, WhalleyET, ForsterC, LyeR, DuttonJ. Prostacyclin and cerebral vessel relaxation. J Neurosurg 1982;57:334–40.
38. OnoueH, KaitoN, AkiyamaM, TomiiM, TokudomeS, AbeT. Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J Neurosurg 1995;83:510–15.
39. KimP, LorenzRR, SundtTM, Jr., VanhouttePM. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg 1989;70:108–14.
40. KimP, SchiniVB, SundtTM, Jr., VanhouttePM. Reduced production of cgmp underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992;70:248–56.
41. KimP, SundtTM, Jr., VanhouttePM. Alterations in endothelium-dependent responsiveness of the canine basilar artery subarachnoid hemorrhage. J Neurosurg 1988;69:239–46.
42. OhlsteinEH, StorerBL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992;77:274–8.
43. HamannGF, del ZoppoGJ. Leukocyte involvement in vasomotor reactivity of the cerebral vasculature. Stroke 1994;25:2117–19.
44. FujimoriA, YanagisawaM, SaitoA, et al. Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 1990;336:633.
45. KrausGE, BucholzRD, YoonKW, KnuepferMM, SmithKR, Jr.Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol 1991;35:20–9.
46. MatsumuraY, IkegawaR, SuzukiY, et al. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 1991;49:841–8.
47. VajkoczyP, MeyerB, WeidauerS, et al. Clazosentan (axv-034343), a selective endothelin a receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase iia study. J Neurosurg 2005;103:9–17.
48. WeirB, MacDonaldL. Cerebral vasospasm. Clin Neurosurg 1993;40:40–55.
49. WilkinsRH, LevittP. Intracranial arterial spasm in the dog. A chronic experimental model. J Neurosurg 1970;33:260–9.
50. ConwayLW, McDonaldLW. Structural changes of the intradural arteries following subarachnoid hemorrhage. J Neurosurg 1972;37:715–23.
51. PeerlessSJKN, KomatsuK, HunterIG. Cerebral vasospam, acute proliferative vasculopathy?. Proceeding of the Second International Workshop. 1979:88–96.
52. SmithRR, ClowerBR, GrotendorstGM, YabunoN, CruseJM. Arterial wall changes in early human vasospasm. Neurosurgery 1985;16:171–6.
53. TanabeY, SakataK, YamadaH, ItoT, TakadaM. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study. J Neurosurg 1978;49:229–38.
54. YamashimaT, HayashiM, SatoK, HayaseH, YamamotoS. [pathology of myonecrosis following cerebral vasospasm]. Neurol Med Chir (Tokyo). 1984;24:335–42.
55. YamamotoY, BernankeDH, SmithRR. Accelerated non-muscle contraction after subarachnoid hemorrhage: cerebrospinal fluid testing in a culture model. Neurosurgery 1990;27:921–8.
56. AlksneJF, GreenhootJH. Experimental catecholamine-induced chronic cerebral vasospasm. Myonecrosis in vessel wall. J Neurosurg 1974;41:440–5.
57. BassiouniH, SchulzR, DorgeH, StolkeD, HeuschG. The impact of subarachnoid hemorrhage on regional cerebral blood flow and large-vessel diameter in the canine model of chronic vasospasm. J Stroke Cerebrovasc Dis 2007;16:45–51.
58. KozniewskaE, MichalikR, RafalowskaJ, et al. Mechanisms of vascular dysfunction after subarachnoid hemorrhage. J Physiol Pharmacol 2006;57 Suppl 11:145–60.
59. SunBL, ZhengCB, YangMF, YuanH, ZhangSM, WangLX. Dynamic alterations of cerebral pial microcirculation during experimental subarachnoid hemorrhage. Cell Mol Neurobiol 2009;29:235–41.
60. YundtKD, GrubbRL, Jr., DiringerMN, PowersWJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 1998;18:419–24.
61. UhlE, LehmbergJ, SteigerHJ, MessmerK. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 2003;52:1307–15; discussion 1315–17.
62. VergouwenMD, VermeulenM, CoertBA, StroesES, RoosYB. Microthrombosis after aneurysmal subarachnoid hemorrhage: An additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761–70.
63. CromptonMR. The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964;87:491–510.
64. SchunkH. Spontaneous thrombosis of intracranial aneurysms. Am J roentgenol 1964;91:1327–38.
65. BlackSPWGW. Observations on the relationship between the volume and the size of the orifice of experimental aneurysms. J Neurosurg 1960;17.
66. RomanoJG, FortezaAM, ConchaM, KochS, HerosRC, MorcosJJ, BabikianVL. Detection of microemboli by transcranial doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 2002;50:1026–30; discussion 1030–1.
67. ChavezL, TakahashiA, YoshimotoT, SuCC, SugawaraT, FujiiY. Morphological changes in normal canine basilar arteries after transluminal angioplasty. Neurol Res 1990;12:12–16.
68. YamamotoY, SmithRR, BernankeDH. Mechanism of action of balloon angioplasty in cerebral vasospasm. Neurosurgery 1992;30:1–5; discussion 5–6.
69. ZubkovYN, AlexanderLF, SmithRR, BenashviliGM, SemenyutinV, BernankeD. Angioplasty of vasospasm: is it reasonable? Neurol Res 1994;16:9–11.
70. EskridgeJM, NewellDW, PendletonGA. Transluminal angioplasty for treatment of vasospasm. Neurosurg Clin N Am 1990;1:387–99.
71. HigashidaRT, HalbachVV, CahanLD, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 1989;71:648–53.
72. BracardS, PicardL, MarchalJC, et al. Role of angioplasty in the treatment of symptomatic vascular spasm occurring in the post-operative course of intracranial ruptured aneurysms. J Neuroradiol 1990;17:6–19.
73. CoyneTJ, MontaneraWJ, MacdonaldRL, WallaceMC. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 1994;37:391–6.
74. Konishi YTM, SataE. Pta for vasospasm after sah. Tokyo: University of Tokyo Press; 1990.
75. NemotoS AT, TanakaH, Sakamotot, ArugaT, TakakuraK. Percutaneous Transluminal Angioplasty for Cerebral Vasospasm Following Sub-arachnoid Hemorrhage. Tokyo: University of Tokyo Press; 1990.
76. TakahashiA Yt, MizoiK, SugawaraT, FujiiY. Transluminal Balloon Angioplasty for Cerebral Vasospasm after Sub-arachnoid Hemorrage. Tokyo: University of Tokyo Press; 1990.
77. BejjaniGK, BankWO, OlanWJ, SekharLN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998;42:979–86; discussion 986–7.
78. EskridgeJM, McAuliffeW, SongJK, et al. Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 1998;42:510–16; discussion 516–17.
79. FirlikAD, KaufmannAM, JungreisCA, YonasH. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;86:830–9.
80. TerryA, ZipfelG, MilnerE, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 2006;21:E14.
81. NewellDW, EskridgeJ, MaybergM, GradyMS, LewisD, WinnHR. Endovascular treatment of intracranial aneurysms and cerebral vasospasm. Clin Neurosurg 1992;39:348–60.
82. LinskeyME, HortonJA, RaoGR, YonasH. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Case report. J Neurosurg 1991;74:985–90.
83. Le RouxPD, NewellDW, EskridgeJ, MaybergMR, WinnHR. Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg 1994;80:224–9.
84. TeradaT, NakamuraY, YoshidaN, et al. Percutaneous transluminal angioplasty for the m2 portion vasospasm following sah: development of the new microballoon and report of cases. Surg Neurol 1993;39:13–17.
85. LivingstonK, GutermanLR, HopkinsLN. Intraarterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. Am J Neuroradiol. 1993;14:346–7.
86. BoltonTB. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 1979;59:606–718.
87. MiyamotoM, TakayanagiI, OhkuboH, TakagiK. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic amp and cyclic gmp phosphodiesterases. Jpn J Pharmacol. 1976:114–17.
88. OgataMMB, LongheadWM. Observation on the effect of intrathecal papaverine on symptomatic vasospasm. J Neurosurg 1975;38.
89. SegawaHSi, OkadaT, NagayamaI, KitamuraK, SanoK. Efficacy of Intracisternal Papaverine on Symptomatic Vasospasm. New York: Raven Press; 1988.
90. VorkapicP, BevanRD, BevanJA. Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery. J Neurosurg 1991;74:951–5.
91. KassellNF, HelmG, SimmonsN, PhillipsCD, CailWS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–52.
92. KakuY, YonekawaY, TsukaharaT, KazekawaK. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77:842–7.
93. CloustonJE, NumaguchiY, ZoarskiGH, AldrichEF, SimardJM, ZitnayKM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. Am J Neuroradiol 1995;16:27–38.
94. KatohH, ShimaK, ShimizuA, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999;21:195–203.
95. MorganMK, JonkerB, FinferS, HarringtonT, DorschNW. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J Clin Neurosci 2000;7:305–8.
96. SchuknechtB, FandinoJ, YukselC, YonekawaY, ValavanisA. Endovascular treatment of cerebral vasospasm: Assessment of treatment effect by cerebral angiography and transcranial colour doppler sonography. Neuroradiology 1999;41:453–62.
97. MarksMP, SteinbergGK, LaneB. Intraarterial papaverine for the treatment of vasospasm. Am J Neuroradiol 1993;14:822–6.
98. MathisJM, JensenME, DionJE. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 1997;39:90–8.
99. CarhuapomaJR, QureshiAI, TamargoRJ, MathisJM, HanleyDF. Intra-arterial papaverine-induced seizures: Case report and review of the literature. Surg Neurol 2001;56:159–63.
100. SmithWS, DowdCF, JohnstonSC, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004;35:2518–22.
101. BeckerU, EhrhardtC, SchaeferUF, et al. Tissue distribution of moxaverine-hydrochloride in the rabbit eye and plasma. J Ocul Pharmacol Ther 2005;21:210–16.
102. FengL, FitzsimmonsBF, YoungWL, et al. Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: Safety and 2-year experience. Am J Neuroradiol. 2002;23:1284–90.
103. ShahQA, GeorgiadisA, SuriMF, RodriguezG, QureshiAI. Preliminary experience with intra-arterial nicardipine in patients with acute ischemic stroke. Neurocrit Care 2007;7:53–7.
104. ShahQA, MemonMZ, SuriMF, et al. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care 2009; 11(2): 190–8.
105. BadjatiaN, TopcuogluMA, PryorJC, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol. 2004;25:819–26.
106. TejadaJG, TaylorRA, UgurelMS, HayakawaM, LeeSK, ChaloupkaJC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: Initial clinical experience with high-dose infusions. Am J Neuroradiol. 2007;28:844–8.
107. AmentaF, TomassoniD. Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clin Exp Hypertens 2004;26:351–61.
108. KittakaM, GiannottaSL, ZelmanV, et al. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg. 1997;87:731–7.
109. ArakawaY, KikutaK, HojoM, GotoY, IshiiA, YamagataS. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: Report of seven cases. Neurosurgery 2001;48:723–8; discussion 728–30.
110. ContiA, AngileriFF, LongoM, PitroneA, GranataF, La RosaG. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report. Acta Neurochir (Wien) 2008;150:1197–202; discussion 1202.
111. FirlikKS, KaufmannAM, FirlikAD, JungreisCA, YonasH. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol 1999;51:66–74.
112. FraticelliAT, CholleyBP, LosserMR, Saint MauriceJP, PayenD. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008;39:893–8.
113. KeuskampJ, MuraliR, ChaoKH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;108:458–63.
114. LinfanteI, Delgado-MederosR, AndreoneV, GounisM, HendricksL, WakhlooAK. Angiographic and hemodynamic effect of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery 2008;63:1080–6; discussion 1086–7.
115. LiuJK, CouldwellWT. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care 2005;2:124–32.
116. NogueiraRG, LevMH, RoccatagliataL, et al. Intra-arterial nicardipine infusion improves ct perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm. Am J Neuroradiol 2009;30:160–4.
117. NumaguchiY, ZoarskiGH. Intra-arterial papaverine treatment for cerebral vasospasm: Our experience and review of the literature. Neurol Med Chir (Tokyo) 1998;38:189–95.
118. PolinRS, HansenCA, GermanP, ChadduckJB, KassellNF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–64; discussion 1264–7.
119. RomeroCM, MoralesD, RecciusA, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2008; 11(2): 165–71.
120. SuzukiS, ItoO, SayamaT, YamaguchiS, GotoK, SasakiT. Intraarterial injection of colforsin daropate hydrochloride for the treatment of vasospasm after aneurysmal subarachnoid hemorrhage: Preliminary report of two cases. Neuroradiology 2006;48:50–3.
121. TsurushimaH, HyodoA, YoshiiY. Papaverine and vasospasm. J Neurosurg 2000;92:509–11.
122. ZubkovAY, LewisAI, ScalzoD. Transluminal angioplasty and intra-arterial papaverine for the treatment of cerebral vasospasm after ruptured arteriovenous malformations. Surg Neurol 1999;51:75–9; discussion 80.
123. ElliottJP, NewellDW, LamDJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–84.
124. TeradaT, KinoshitaY, YokoteH, et al. The effect of endovascular therapy for cerebral arterial spasm, its limitation and pitfalls. Acta Neurochir (Wien) 1997;139:227–34.
125. HohBL, OgilvyCS. Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005;16:501–16.
126. CoenenVA, HansenCA, KassellNF, PolinRS. Endovascular treatment for symptomatic cerebral vasospasm after subarachnoid hemorrhage: Transluminal balloon angioplasty compared with intraarterial papaverine. Neurosurg Focus 1998;5:e6.
127. JohnstonSC. Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke 2000;31:111–17.
128. JestaedtL, PhamM, BartschAJ, et al. The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2008;62:610–17; discussion 610–17.
129. MegyesiJF, FindlayJM, VollrathB, CookDA, ChenMH. In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses. Stroke 1997;28:1216–24.
130. MuizelaarJP, ZwienenbergM, RudisillNA, HechtST. The prophylactic use of transluminal balloon angioplasty in patients with fisher grade 3 subarachnoid hemorrhage: a pilot study. J Neurosurg 1999;91:51–8.
131. MurayamaY, SongJK, UdaK, et al. Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm. Am J Neuroradiol 2003;24:133–9.
132. QureshiAI, SuarezJI, BhardwajA, YahiaAM, TamargoRJ, UlatowskiJA. Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2000;28:824–9.
133. HarriganMR, MagnanoCR, GutermanLR, HopkinsLN. Computed tomographic perfusion in the management of aneurysmal subarachnoid hemorrhage: new application of an existent technique. Neurosurgery 2005;56:304–17; discussion 317.
134. WintermarkM, DillonWP, SmithWS, et al. Visual grading system for vasospasm based on perfusion ct imaging: comparisons with conventional angiography and quantitative perfusion ct. Cerebrovasc Dis 2008;26:163–70.
135. van der SchaafI, WermerMJ, van der GraafY, HoffRG, RinkelGJ, VelthuisBK. Ct after subarachnoid hemorrhage: Relation of cerebral perfusion to delayed cerebral ischemia. Neurology 2006;66:1533–8.
136. HertelF, WalterC, BettagM, MorsdorfM. Perfusion-weighted magnetic resonance imaging in patients with vasospasm: a useful new tool in the management of patients with subarachnoid hemorrhage. Neurosurgery 2005;56:28–35; discussion 35.
137. BeckJ, RaabeA, LanfermannH, et al. Effects of balloon angioplasty on perfusion- and diffusion-weighted magnetic resonance imaging results and outcome in patients with cerebral vasospasm. J Neurosurg 2006;105:220–7.
138. ChaturvediS, St PierreME, BertasioB. Cerebral angioplasty practice at major medical centers in the United States. Neuroradiology 2000;42:218–20.
139. FandinoJ, KakuY, SchuknechtB, ValavanisA, YonekawaY. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1998;89:93–100.
140. LewisDH, Paul ElliottJ, NewellDW, EskridgeJM, Richard WinnH. Interventional endovascular therapy: Spect cerebral blood flow imaging compared with transcranial doppler monitoring of ballon angioplasty and intraarterial papaverine for cerebral vasospasm. J Stroke Cerebrovasc Dis 1999;8:71–5.
141. MajoieCB, van BovenLJ, van de BeekD, VenemaHW, van RooijWJ. Perfusion ct to evaluate the effect of transluminal angioplasty on cerebral perfusion in the treatment of vasospasm after subarachnoid hemorrhage. Neurocrit Care 2007;6:40–4.
142. MilburnJM, MoranCJ, CrossDT, 3rd, DiringerMN, PilgramTK, DaceyRG, Jr. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 1998;88:38–42.
143. MuraiY, KominamiS, KobayashiS, MizunariT, TeramotoA. The long-term effects of transluminal balloon angioplasty for vasospasms after subarachnoid hemorrhage: analyses of cerebral blood flow and reactivity. Surg Neurol 2005;64:122–6; discussion 127.
144. OhkawaM, FujiwaraN, TanabeM, et al. Cerebral vasospastic vessels: Histologic changes after percutaneous transluminal angioplasty. Radiology 1996;198:179–84.
145. OskouianRJ, Jr., MartinNA, LeeJH, et al. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 2002;51:30–41; discussion 41–3.
146. OhkumaH, ManabeH, TanakaM, SuzukiS. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621–7.
147. OkadaY, ShimaT, NishidaM, et al. [evaluation of angiographic delayed vasospasm due to ruptured aneurysm in comparison with cerebral circulation time measured by ia-dsa]. No Shinkei Geka 1994;22:439–45.
148. FronteraJA, FernandezA, SchmidtJM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?Stroke 2009;40:1963–8.
149. HanggiD, TurowskiB, BeseogluK, YongM, SteigerHJ. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Influence on clinical course and cerebral perfusion. Am J Neuroradiol 2008;29:1053–60.
150. TariqN, QureshiMN, SuriMFK, et al. Compliant versus non-compliant balloons for endovascular treatment of vasospasm after subarachnoid hemorrhage. American Academy of Neurology 61st Annual Meeting. 2009.
151. Schmid-ElsaesserR, KunzM, ZausingerS, PruecknerS, BriegelJ, SteigerHJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006;58:1054–65; discussion 1054–65.
152. BoetR, MeeE. Magnesium sulfate in the management of patients with fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000;47:602–6; discussion 606–7.
153. MilburnJM, MoranCJ, CrossDT, 3rd, DiringerMN, PilgramTK, DaceyRG, Jr. Effect of intraarterial papaverine on cerebral circulation time. Am J Neuroradiol 1997;18:1081–5.
154. LiuJK, TennerMS, GottfriedON, et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 2004;100:414–21.
155. AndaluzN, TomsickTA, TewJM, Jr., van LoverenHR, YehHS, ZuccarelloM. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the university of cincinnati. Surg Neurol 2002;58:131–8; discussion 138.
156. RabinsteinAA, FriedmanJA, NicholsDA, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. Am J Neuroradiol 2004;25:1778–82.
157. RosenwasserRH, ArmondaRA, ThomasJE, BenitezRP, GannonPM, HarropJ. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 1999;44:975–9; discussion 979–80.
158. PolinRS, CoenenVA, HansenCA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284–90.
159. ArmondaRA, BellRS, VoAH, et al. Wartime traumatic cerebral vasospasm: Recent review of combat casualties. Neurosurgery 2006;59:1215–25; discussion 1225.
160. QureshiAI, FrankelMR, OttenlipsJR, SternBJ. Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol 1996;53:1226–31.
161. RingerAJ, QureshiAI, KimSH, FesslerRD, GutermanLR, HopkinsLN. Angioplasty for cerebral vasospasm from eclampsia. Surg Neurol 2001;56:373–8; discussion 378–9.
162. IA K. Cerebral vasospasm in intracerebral hemorrhage-case report. J Vasc and Interventional Neurol 2009;2:139–41.
163. ZubkovAY, LewisAI, ScalzoD, BernankeDH, HarkeyHL. Morphological changes after percutaneous transluminal angioplasty. Surg Neurol 1999;51:399–403.
164. PetrukKC, WestM, MohrG, et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505–17.
165. WeidauerS, LanfermannH, RaabeA, ZanellaF, SeifertV, BeckJ. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective mri and dsa study. Stroke 2007;38:1831–6.
166. KoNU, RajendranP, KimH, et al. Endothelial nitric oxide synthase polymorphism (-786t->c) and increased risk of angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008;39:1103–8.
167. UdoetukJD, StiefelMF, HurstRW, WeigeleJB, LeRouxPD. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007;61:1152–9; discussion 1159–61.
168. SutherlandGR, KingME, PeerlessSJ, VezinaWC, BrownGW, ChamberlainMJ. Platelet interaction within giant intracranial gneurgsms. J Neurosurg 1982;56(1):53–61.